Clinical trial
The Efficacy and Safety of Losartan/Hydrochlorothiazide Combination Drug (Preminent) in Patients With Morning Hypertension
NCT00795847 is registered in ClinicalTrials.gov with Kurume University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Efficacy and Safety of Losartan/Hydrochlorothiazide Combination Drug (Preminent) in Patients With Morning Hypertension
- Lead sponsor
- Kurume University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 30, 2008
- Completion date
- November 30, 2010
- Enrollment
- 216 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.